ALPHARETTA, Ga., June 11, 2018 /PRNewswire/ -- Halyard
Health, Inc. (NYSE: HYH) announced today that the company will
host its Analyst and Investor Conference on Thursday, June 21, 2018, at the Sofitel New York
from 7:30 a.m. to approximately
12:30 p.m. ET. The conference will
feature presentations from Halyard leadership beginning at
8 a.m. and concluding at
approximately 11:30 a.m. Following
the presentations, from 11:30 a.m. to 12:30
p.m., the company will display some of its breakthrough
technologies at its R&D and Product Showcase.
Space for the event is limited; therefore, attendance is by
invitation only. Institutional investors, equity research analysts
and debt analysts interested in attending are encouraged to contact
Halyard Investor Relations at Investor.Relations@HYH.com as soon as
possible to request an invitation.
Halyard Health will host a webcast of the meeting to provide
access to all interested stakeholders. The simultaneous webcast can
be accessed via the Investors section of the Halyard Health
website, https://halyardhealth.investorroom.com/. Slides from the
meeting will be available to those viewing the webcast. Within 24
hours of the webcast, a replay including presentation slides will
be accessible in the Investors section of the website.
About Halyard Health
Halyard Health (NYSE: HYH) is a medical technology company focused
on delivering clinically superior breakthrough medical device
solutions to improve patients' quality of life. Headquartered
in Alpharetta, Georgia, Halyard is
committed to addressing some of today's most important healthcare
needs, such as reducing the use of opioids while helping patients
move from surgery to recovery. Halyard develops, manufactures and
markets its recognized brands in more than 90 countries. For more
information, visit www.halyardhealth.com.
As previously announced, Halyard Health is changing its name to
Avanos Medical, Inc., effective June 30,
2018. Its current ticker symbol on the New York Stock
Exchange (HYH) is also changing at that time to AVNS. The first day
of trading under the new ticker symbol will be July 2, 2018.
View original
content:http://www.prnewswire.com/news-releases/halyard-health-announces-2018-analyst-and-investor-conference-and-webcast-300662577.html
SOURCE Halyard Health, Inc.